The Journal of Infectious Diseases · 1998 · 28 citations · 29 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsBacterial InfectionsBeta-lactam ResistanceTreatment Of EndocarditisHydrolysisInfectious EndocarditisMethicillin ResistanceMethicillin-resistant Staphylococcus Aureus EndocarditisMethicillin-resistant Staphylococcus Aureus Infection TreatmentMethicillin-resistant Staphylococcus Aureus TreatmentPenicillin ResistanceStaphylococcal Infection Therapy
Beta-lactams active against methicillin-resistant Staphylococcus aureus (MRSA) must resist penicillinase hydrolysis and bind penicillin-binding protein 2A (PBP 2A). Cefamandole might share these properties. When tested against 2 isogenic pairs of MRSA that produced or did not produce penicillinase, MICs of cefamandole (8-32 mg/L) were not affected by penicillinase, and cefamandole had a > or =40 times greater PBP 2A affinity than did methicillin. In rats, constant serum levels of 100 mg/L cefamandole successfully treated experimental endocarditis due to penicillinase-negative isolates but failed against penicillinase-producing organisms. This suggested that penicillinase produced in infected vegetations might hydrolyze the drug. Indeed, cefamandole was slowly degraded by penicillinase in vitro. Moreover, its efficacy was restored by combination with sulbactam in vivo. Cefamandole also uniformly prevented MRSA endocarditis in prophylaxis experiments, a setting in which bacteria were not yet clustered in the vegetations. Thus, while cefamandole treatment was limited by penicillinase, the drug was still successful for prophylaxis of experimental MRSA endocarditis.
29
Manual of Clinical Microbiology.
Annals of Internal Medicine · 1980 · 14.5K citations
Natural history of aortic valve endocarditis in rats
E Héraïef, M. P. Glauser, Lawrence R. Freedman · Infection and Immunity · 1982 · 129 citations · Full text